10x Genomics, Inc. — Director's Dealing 2020

Apr 23, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2020-04-21

Reporting Person: Hindson Benjamin J. (Director, See Remarks, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-21	Stock Option (right to buy)	$74.58	A	136000	Acquired	2030-04-21	Class A Common Stock (136000)	Direct

Footnotes

F1: This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one forty-eighth of the shares on May 1, 2020 and each month thereafter, subject to the reporting person continuing as a service provider through each such date.